Identification and validation of anti-protein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc).
Minrui LiangLingbiao WangXiaolong TianKun WangXiaoyi ZhuLinlin HuangQing LiWenjing YeChen ChenHaihua YangWanqing WuXiangjun ChenXiaoxia ZhuYu XueWeiguo WanYanling WuLiwei LuJiucun WangHejian ZouTianlei YingFeng ZhouPublished in: Annals of the rheumatic diseases (2024)
This study has identified anti-PRMT5 antibodies as a novel biomarker for SSc.